Article: New Prescription Allergy Treatment XYZAL(R) (Levocetirizine Dihydrochloride) Now Available for Fall Allergy Season.

ATLANTA and BRIDGEWATER, N.J., Oct. 2 /PRNewswire-FirstCall/ -- UCB and sanofi-aventis announced today that XYZAL(R), a new once-daily medication used to treat indoor and outdoor allergies, as well as chronic idiopathic urticaria, is now available by prescription in the U.S. XYZAL(R) is an oral antihistamine that has been shown to provide powerful allergy symptom relief. XYZAL(R) is approved for use in adults and children 6 years and older.

"Allergy patients need a prescription treatment option that works quickly to relieve their suffering," said Michael S. Blaiss, MD, Clinical Professor of Pediatrics and Medicine at the University of Tennessee Health Science ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!